Value of Sextant Biopsies in the Assessment of Local Cure Following External Beam Radiotherapy of Prostatic Adenocarcinoma

REFERENCES

• Babaian RJ, Kojima M, Saitih M, Ayala AG. Detection of residual prostate cancer after external radiotherapy. Cancer 1995; 75: 2153–2158.
   PubMed Web of Science ®Google Scholar
• Bagshaw MA, Kaplan ID, Cox RC. Radiation therapy for localized disease. Cancer 1993; 71: 939–952.
   Google Scholar
• Cancer Incidence in Sweden 1989, National Board of Health and Welfare The Cancer Registry 1990.
   Google Scholar
• Cangh PJ, Richard FJ. Prostate-specific antigen after definitive radiation therapy. Urology 1994; 4: 256–260.
   Google Scholar
• Crook JM, Perry GA, Robertson S, Esche BA. Routine prostate biopsies following radiotherapy for prostate cancer; results for 226 patients. Urology 1995; 45: 624–632.
   PubMed Web of Science ®Google Scholar
• Crook J, Robertson S, Collin G, Zaleski V, Esche B. Clinical relevance of trans-rectal ultrasound, biopsy, and serum prostate-specific antigen following external beam radiotherapy for carcinoma of the prostate. Int J Radiat Oncol Biol Phys 1993; 27: 31–37.
   Google Scholar
• de la Torre M, Häggman M, Brändstedt S, Busch C. Prostatic intraepithelial neoplasia and invasive carcino-ma in total prostatectomy specimens: distribution, volumes and DNA ploidy. Br J Urol 1993; 72: 207–213.
   PubMedGoogle Scholar
• Dughan TC, Shipley WU, Young RH, Verhey LJ, Althausen AF, Heney NM, et al. Biopsy after external radiation therapy for adenocarcinoma of the prostate: correlation with original histological grade and current prostate specific antigen level. J Urol 1991; 146: 1313–1316.
   PubMed Web of Science ®Google Scholar
• Freiha FS, Bagshaw MA. Carcinoma of the prostate: results of post-irradiation biopsy. The Prostate 1984; 5: 19–25.
   PubMed Web of Science ®Google Scholar
• Fuks Z, Leibel SA, Wallner KE, Begg CB, Fair WR, Anderson LL, et al. The effect on local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 1251 implan-tation. Int J Radiat Oncol Biol Phys 1991; 21: 537–547.
   PubMed Web of Science ®Google Scholar
• Gleason FD, Mellinger GT. The Veterans Administra-tion Cooperative Urological Research Group. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974; 111: 58–64.
   Google Scholar
• Grayhack JT. The management of clinically localized prostate cancer. National Institutes of Health Consensus Development Conference. J Urol 1987; 138: 1369–1375.
   Google Scholar
• Hanks GE, Perez CA, Kozar M, Asbell SO, Pilepich MV, Pajak TF. PSA confirmation of cure at 10 years of T1B, T2, NO, MO. Prostate cancer patients treated in RTOG protocol 7706 with external beam radiation. Int J Radiat Oncol Biol Phys 1994; 30: 289–292.
   Google Scholar
• Herr HW, Whitmore Jr WF. Significance of prostatic biopsies after radiation therapy for carcinoma of the prostate. The Prostate 1982; 3: 339–350.
   PubMed Web of Science ®Google Scholar
• ICRU Report 50. Prescribing, recording, and reporting photon beam therapy..
   Google Scholar
• Kabalin JN, Hodge KK, McNeal JE, Freiha FS, Stamey TA. Identification of residual cancer in the prostate following radiation therapy: role of transrectal ultra-sound guided biopsy and prostate specific antigen. J Urol 1989; 142: 326–331.
   Google Scholar
• Kiesling VJ, McAninch JVV, Goebel JL, Agee RE. External beam radiotherapy for adenocarcinoma of the prostate: a clinical follow-up. J Urol 1980; 124: 851–854.
   PubMed Web of Science ®Google Scholar
• Kirk J, Gray WM, Watson ER. Cumulative radiation effect part I: Fractionated treatment regimes. Clin Radiol 1971; 22: 145–155.
   Google Scholar
• Kuban DA, El-Madhi AM. Radiotherapy in the treat-ment of apparently localized prostatic carcinoma. In: Controversies in the management of prostate cancer. CoMed Communications, 1990; part 3: 4.
   Google Scholar
• Kuban DA, El-Madhi AM, Schellhammer P. The signi-ficance of post-irradiation prostate biopsy with long-term follow-up. Int J Radiat Oncol Biol Phys 1992; 24: 409–414.
   PubMed Web of Science ®Google Scholar
• Leach GE, Cooper if, Kagan AR, Snyder R, Forsthe A. Radiotherapy for prostatic carcinoma: post-irradiation prostatic biopsy and recurrence patterns with long-term follow-up. J Urol 1982; 128: 505–509.
   Google Scholar
• Ljung G. Radiotherapy of prostatic adenocarcinoma with reference to local cure, characterization of residual tumour cells, adverse effects. Comprehensive summa-ries of Uppsala dissertations from the Faculty of Medi-cine 630, Acta Universitatis Upsaliensis, Uppsala 1996: 14–16.
   Google Scholar
• Ljung G, Norberg M, Hansson H, de la Torre M, Egevad L, Holmberg L, et al. Transrectal ultrasonically guided core biopsies in the assessment of local cure of prostatic cancer after radical external beam radiotherapy. Acta Oncol 1995; 34: 945–952.
   Google Scholar
• Lytton B, Collins JT, Weiss RM, Schiff Jr M, McGuire EJ, Livolsi V. Results of biopsy after early stage prostatic cancer treatment by implant of 1251 seeds. J Urol 1979; 121: 306–309.
   Google Scholar
• McLoughlin M, Hazra T, Schirmer HK, Scott WW. Telecobalt therapy for prostatic cancer: rationale, results and future considerations. J Urol 1975; 113: 378–379.
   PubMed Web of Science ®Google Scholar
• Mostofi FK. Grading of prostatic carcinoma. Cancer Chem Rep 1975; 59: 111–117.
   PubMedGoogle Scholar
• Nachtsheim DA, McAninch, Stutzman RE, Goebel JL. Latent residual tumor following external radiotherapy for prostate adenocarcinoma. J Urol 1978; 120: 312–314.
   PubMed Web of Science ®Google Scholar
• Norberg M, Holmberg L, Magnusson A. Determinants of complications after multiple transrectal core biopsies of the prostate. 1994 Submitted for publication..
   Google Scholar
• Norberg M, Häggman M, Andersson T, Busch C, Magnusson A. Evaluation of localised prostate cancer: a comparative study of transrectal ultrasonography versus histopathology. Eur Radiol 1993; 3: 166–173.
   Google Scholar
• Prestidge BR, Kaplan I, Cox RS, Bagshaw MA. The clinical significance of a positive postirradiation pro-static biopsy without metastases. Int J Radiol Oncol Biol Phys 1992; 24: 403–408.
   PubMed Web of Science ®Google Scholar
• Ritter MA, Messing EM, Shanahan TG, Potts S, Chapell RJ, Kinsella TJ. Prostate-specific antigen as a predictor of radiotherapy response and patterns of failure in localized prostate cancer. J Clin Oncol 1992; 10: 1208–1217.
   PubMed Web of Science ®Google Scholar
• Rhamy RK, Wilson SK, Caldwell WL. Biopsy-proved tumor following definitive irradiation for resectable carcinoma of the prostate. J Urol 1972; 107: 627–630.
   Google Scholar
• Scardino PT, Frankel IM, Wheeler TM, Meacham RB, Hoffman GS, Seale C, et al. The prognostic significance of post-irradiation biopsy results in patients with prostatic cancer. J Urol 1986; 135: 510–516.
   PubMed Web of Science ®Google Scholar
• Schellhammer PF, El-Mahdi AM, Higgins EM, Schultheiss TE, Ladaga LE, Babb TJ. Prostate biopsy after definitive treatment by interstitial 125Iodine implant or external beam radiation therapy. J Urol 1987; 137: 897–901.
   PubMed Web of Science ®Google Scholar
• Sewell RA, Braren V, Wilson SK, Rhamy RK. Extended biopsy follow-up after full course radiation for resect-able prostatic carcinoma. J Urol 1975; 113: 371–373.
   PubMed Web of Science ®Google Scholar
• Stamey TA. Making the most out of six systematic biopsies. Urology 1995; 45: 2–12.
   PubMed Web of Science ®Google Scholar
• Stamey TA, Ferrari MK, Schmid H-P. The value of serial prostate specific antigen determinations 5 years after radiotherapy: steeply increasing values character-ize 80% of patients. J Urol 1993; 150: 1856–1859.
   Google Scholar
• Stamey TA, Kabalin IN, Ferrari M. Prostate specific antigen in the diagnosis and treatment of adenocarcino-ma of the prostate III. Radiation treated patients. J Urol 1989; 141: 1084–1087.
   Google Scholar
• Zelefsky MJ, Leibel SA, Wallner KE, Whitmore WF, Fuks Z. Significance of normal serum prostate-specific antigen in the follow-up period after definitive radiation therapy for prostate cancer. J Clin Oncol 1995; 13: 459–463.
   Google Scholar